Bristol-Myers Squibb Company (BMY)
NYSE · Healthcare
Bristol-Myers Squibb Company Revenue 2007–2025
Bristol-Myers Squibb Company annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bristol-Myers Squibb Company revenue for the quarter ending March 31, 2026 was 11.5 B, a 2.57% increase year-over-year.
- Bristol-Myers Squibb Company revenue for the twelve months ending March 31, 2026 was 47.2 B, a 0.55% increase year-over-year.
- Bristol-Myers Squibb Company annual revenue for 2025 was 48.2 B, a 0.22% decrease from 2024.
- Bristol-Myers Squibb Company annual revenue for 2024 was 48.3 B, a 7.32% increase from 2023.
- Bristol-Myers Squibb Company annual revenue for 2023 was 45.0 B, a 2.50% decrease from 2022.
- Bristol-Myers Squibb Company annual revenue for 2022 was 46.2 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bristol-Myers Squibb Company Market Cap — FAQ
Bristol-Myers Squibb Company (BMY) market cap over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMY's market cap history?
The chart and table above show Bristol-Myers Squibb Company's market cap by year and by quarter, including the growth rate.